Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

BACKGROUND: Over the past five years, in most hospitals in England and Wales, incident reporting has become well established but it remains unclear how well reports match clinical adverse events. International epidemiological studies of adverse events are based on retrospective, multi-hospital case...

Повний опис

Бібліографічні деталі
Автори:	Olsen, S, Neale, G, Schwab, K, Psaila, B, Patel, T, Chapman, E, Vincent, C
Формат:	Journal article
Мова:	English
Опубліковано:	2007

Схожі ресурси

The reasons of the nursing staff to notify adverse events
за авторством: Miriam Cristina Marques da Silva de Paiva, та інші
Опубліковано: (2014-10-01)

Role of the Clinical Pharmacist in Reducing Preventable Adverse Drug Events
за авторством: Bahir A.Mshiemish
Опубліковано: (2017-03-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
за авторством: Colleen M. Kingsbury, та інші
Опубліковано: (2024-09-01)

In light of recent events, we may have to see adverse effect profile in new perspective
за авторством: Sahjid Mukhida, та інші
Опубліковано: (2024-11-01)

Internal Strengths for Adverse Life Events
за авторством: Jian Zhao, та інші
Опубліковано: (2024-08-01)

Exploring the causes of adverse events in NHS hospital practice.
за авторством: Neale, G, та інші
Опубліковано: (2001)

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database
за авторством: Tingting Jiang, та інші
Опубліковано: (2025-01-01)

Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
за авторством: Nicholls J, та інші
Опубліковано: (2017-02-01)

Failure to obtain informed consent should also be considered an adverse event
за авторством: Gabriel M. Fonseca, та інші
Опубліковано: (2020-06-01)

Adverse events in British hospitals: preliminary retrospective record review.
за авторством: Vincent, C, та інші
Опубліковано: (2001)

Case record review of adverse events: a new approach.
за авторством: Woloshynowych, M, та інші
Опубліковано: (2003)

Adverse event management
за авторством: Aline Gonzalez Vigani

The Adverse Event Paradox
за авторством: Thomas Milovac
Опубліковано: (2022-05-01)

Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
за авторством: Tanattha Kitisopee, та інші
Опубліковано: (2022-12-01)

Embedding surveillance into clinical care to detect serious adverse events in pregnancy
за авторством: Seale, A, та інші
Опубліковано: (2015)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
за авторством: Xuejiao Pan, та інші
Опубліковано: (2022-01-01)

PrePex circumcision surveillance: Adverse events and analgesia for device removal.
за авторством: Limakatso Lebina, та інші
Опубліковано: (2018-01-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
за авторством: Astri Budikayanti, та інші
Опубліковано: (2018-01-01)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
за авторством: Ming-Tao Wen, та інші
Опубліковано: (2024-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
за авторством: Bin Zhao, та інші
Опубліковано: (2018-10-01)

AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
за авторством: Yiming Li, та інші
Опубліковано: (2024-01-01)

Adverse events following immunization among the elderly having booster COVID-19 vaccine: an active surveillance in Guiyang city
за авторством: Na YU, та інші
Опубліковано: (2022-09-01)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
за авторством: Donaldson M, та інші
Опубліковано: (2013-06-01)

Understanding and responding to adverse events.
за авторством: Vincent, C
Опубліковано: (2003)

Minor Adverse Events Postcolonoscopy
за авторством: Catherine Dubé
Опубліковано: (2014-01-01)

Evaluating adverse events in databases
за авторством: Katie Lovell, та інші
Опубліковано: (2023-10-01)

Adverse Events of DOACs in Children
за авторством: Alessandra Bosch, та інші
Опубліковано: (2022-07-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
за авторством: Wei Mao, та інші
Опубліковано: (2025-01-01)

Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
за авторством: Fan Wu, та інші
Опубліковано: (2024-06-01)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
за авторством: Kaito Yamashiro, та інші
Опубліковано: (2022-10-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
за авторством: Han N, та інші
Опубліковано: (2021-08-01)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
за авторством: Dong-Hui Lao, та інші
Опубліковано: (2021-06-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
за авторством: Li Sun, та інші
Опубліковано: (2024-12-01)

Reinforcing Surveillance for Vaccine-Associated Adverse Events: The Advisory Committee on Causality Assessment
за авторством: Robert Pless, та інші
Опубліковано: (1996-01-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
за авторством: WANG Qian, та інші
Опубліковано: (2022-04-01)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
за авторством: Yunha Noh, та інші
Опубліковано: (2023-06-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
за авторством: AbdulAzeez Adeyemi Anjorin, та інші
Опубліковано: (2022-04-01)

Active surveillance study of adverse events following immunisation of children in the Czech Republic
за авторством: Jana Danova, та інші
Опубліковано: (2017-02-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
за авторством: Patrícia Cabral Ferreira, та інші
Опубліковано: (2014-03-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
за авторством: Patrícia Cabral Ferreira, та інші
Опубліковано: (2014-03-01)